The characterization of psychotic symptoms in succinic semialdehyde dehydrogenase deficiency: a review.

doi:10.1097/YPG.0000000000000264

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The characterization of psychotic symptoms in succinic semialdehyde dehydrogenase deficiency: a review.

Psychiatric genetics - 1 Dec 2020

Colijn Mark A

Abstract excerpt

Succinic semialdehyde dehydrogenase (SSADH) deficiency is an ultra-rare inborn error of metabolism that results in disrupted gamma-amino butyric acid (GABA) catabolism. In addition to developmental delay, intellectual disability, hypotonia, ataxia, and seizures, a variety of neuropsychiatric symptoms may occur, including psychosis. By highlighting all available and relevant case reports/series, this qualitative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aggression
Share to Amino Acid Metabolism, Inborn Errors
Share to Anxiety Disorders
Share to gamma-Aminobutyric Acid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hallucinations

Share to Psychotropic Drugs

Share to Symptom Assessment

Share to Valproic Acid

Source

Open in PubMed

Identifiers

PMID: 33165204
DOI: 10.1097/YPG.0000000000000264

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.